Form 4: Veradigm CHRO Tally Baker Awarded 105,999 RSUs

Veradigm Inc.'s Chief Human Resources Officer, Tally Baker, was granted 105,999 Restricted Stock Units under the company's 2024 Stock Incentive Plan.

Summary

• Tally Baker, Chief Human Resources Officer (CHRO) of Veradigm Inc., acquired 105,999 shares of common stock.
• The acquisition was an award of Restricted Stock Units (RSUs) granted under the Veradigm, Inc. Amended and Restated 2024 Stock Incentive Plan.
• The RSUs were granted on November 3, 2025, with a vesting schedule of 25% on each of the first four anniversaries of the grant date.
• The reported transaction price was $0.00, as executives do not pay consideration for Restricted Stock Units at the time of grant, a reporting practice the company will continue for similar grants.

Sentiment

Score: 7

Explanation: The grant of Restricted Stock Units to a key executive is a positive for aligning management incentives with long-term shareholder value. It's a standard compensation practice and does not indicate any immediate negative operational or financial issues, thus a moderately positive sentiment.

Positives

• The grant of 105,999 Restricted Stock Units to a key executive (CHRO) aligns management incentives with long-term shareholder interests.
• The award is part of the Veradigm, Inc. Amended and Restated 2024 Stock Incentive Plan, indicating a structured and approved approach to executive compensation.

Future Outlook

The Restricted Stock Units are scheduled to vest 25% on each of the first four anniversaries of the grant date (November 3, 2025), indicating future share ownership for the executive contingent on continued employment and performance.

Industry Context

Granting Restricted Stock Units is a common practice in the healthcare IT and software industry to attract, retain, and incentivize key executives, aligning their long-term interests with company performance and shareholder value. This practice is consistent with compensation strategies observed across the sector.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) as a compensation tool is standard practice across technology and healthcare sectors, comparable to companies like Cerner (now Oracle Health) or Allscripts Healthcare Solutions (now part of Veradigm) for their executive compensation.
• A four-year vesting schedule with annual tranches is typical for executive equity awards, similar to practices at publicly traded peers such as Teladoc Health (TDOC) or GoodRx (GDRX) for their senior leadership, ensuring long-term commitment.

Corporate Governance

Related Party Transactions

• Award of 105,999 Restricted Stock Units to Tally Baker, CHRO, as part of an approved executive compensation plan.

Stakeholder Impact

• Shareholders: Potential long-term benefit from incentivized management, but also potential future dilution from the issuance of shares upon RSU vesting.
• Employees: Standard executive compensation practices can signal stability and a structured approach to rewarding leadership within the company.

Next Steps

• The 105,999 Restricted Stock Units will vest in four equal annual installments of 25% on each anniversary of November 3, 2025.

Key Dates

Recommendation

This Form 4 reports a routine executive compensation grant of Restricted Stock Units. While it aligns executive incentives with shareholder interests, it does not present new information that would fundamentally alter the investment thesis for Veradigm Inc. Therefore, a 'hold' recommendation is appropriate, maintaining current positions based on broader company fundamentals rather than this specific filing.

Keywords

Veradigm Inc., MDRX, Form 4, Restricted Stock Units, RSU, Insider Transaction, Executive Compensation, Tally Baker, CHRO, Stock Incentive Plan